Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
United Kingdom childhood Acute Lymphoblastic Leukaemia Randomised Trial 2003
Source of recordUK Trials
ISRCTNISRCTN07355119
Date ISRCTN assigned18/08/2003
Local reference number(s)G0300130
Public titleUnited Kingdom childhood Acute Lymphoblastic Leukaemia Randomised Trial 2003
Scientific title
AcronymMRC UKALL 2003
Disease/condition/study domainLeukaemia
Study hypothesisOptimise treatment of childhood ALL by stratification according to on-treatment monitoring of minimal residual disease.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration.
Countries of trialUnited Kingdom
Participants - inclusion criteriaChildren aged 1-18 years with Acute Lymphoblastic Leukaemia (ALL)
Participants - exclusion criteria1. Mature B ALL
2. Infant ALL (age <1 year)
3. Philadelphia positive ALL
Patient information material
Anticipated start date01/10/2003
Anticipated end date30/09/2009
Status of trialOngoing
Target number of participants2500
InterventionsMRD High Risk group randomised to standard vs intensified therapy

MRD Low Risk group randomised to standard vs reduced therapy
Primary outcome measure(s)1. Event-Free Survival
2. Survival
3. Quality of Life
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingMedical Research Council (G0300130) (UK)
Leukaemia Research Fund (0301) (UK)
Sponsor nameMedical Research Council (UK)
Sponsor details20 Park Crescent
London
United Kingdom
W1B 1AL
Sponsor telephone+44 (0)20 7670 5259
Sponsor fax+44 (0)20 7636 6289
Sponsor emailclinical.trial@headoffice.mrc.ac.uk
Contact nameDr Ajay Vora
Contact detailsRoald Dahl Paediatric Haematology Centre
Sheffield Children's Hospital
SHEFFIELD
United Kingdom
S10 2TH
Contact telephone+44 (0)114 2717477
Contact fax+44 (0)1142762289
Contact emailajay.vora@sch.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN07355119
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central